Evidence-Based Medicine Guidelines
Lipid-lowering efficacy of rosuvastatin
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Lipid-lowering Efficacy of Rosuvastatin." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458368/all/_________Lipid_lowering_efficacy_of_rosuvastatin______.
Lipid-lowering efficacy of rosuvastatin. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/458368/all/_________Lipid_lowering_efficacy_of_rosuvastatin______. Accessed April 28, 2025.
Lipid-lowering efficacy of rosuvastatin. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/458368/all/_________Lipid_lowering_efficacy_of_rosuvastatin______
Lipid-lowering Efficacy of Rosuvastatin [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458368/all/_________Lipid_lowering_efficacy_of_rosuvastatin______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lipid-lowering efficacy of rosuvastatin
ID - 458368
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458368/all/_________Lipid_lowering_efficacy_of_rosuvastatin______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
